https://www.marketscreener.com/quote/stock/SUMITOMO-PHARMA-CO-LTD-6492512/news/Sumitomo-Pharma-Start-of-Investigator-Initiated-Clinical-Study-of-iPS-Cell-Derived-Dopaminergic-Pr-45632577/?utm_source=telegram&utm_medium=social&utm_campaign=share